SARS-COV-2 INFECTION

This early-stage study tests a new vaccine designed to protect against multiple coronaviruses, including COVID-19 and potential future threats. About 51 healthy adults aged 18-55 will receive two doses to check safety and how well the vaccine triggers an immune response. The goal…

This study tests an updated COVID-19 vaccine designed for the 2025-2026 season in people 12 and older who are at higher risk of severe illness, including those 65+. About 760 participants will receive one shot and be monitored for safety and immune response over 6 months. The goa…

This study tests an updated COVID-19 vaccine (2025/2026 formula) in 343 children aged 5 to 11 who have health conditions that put them at high risk for severe COVID-19. Each child receives one shot and is followed for about 6 months to check safety and immune response. The goal i…

This study tests a new vaccine designed to protect against the Omicron JN.1 variant of COVID-19. About 120 adults aged 65 and older, and teens and adults aged 12 to 64 with health conditions that raise their risk for severe COVID, will receive a single shot. Researchers will chec…

This study tests whether an updated COVID-19 vaccine can safely protect healthy adults aged 50 to 64 from the virus. About 5,240 participants will receive either the variant-adapted vaccine or a placebo. Researchers will monitor side effects and track how many people get COVID-19…

This study tests a single dose of a new COVID-19 vaccine designed to protect against the JN.1 variant. About 6,500 healthy adults aged 50 to 64 who are not at high risk for severe COVID will receive either the vaccine or a placebo. Researchers will track who gets sick with COVID …

This study gives healthy volunteers who have had a COVID-19 vaccine or prior infection a small dose of the Omicron BA.5 virus through the nose. The goal is to find the right dose that causes infection in 50-75% of people and to monitor safety and how the virus spreads. 45 partici…

This study follows about 15,000 children and young adults (ages 0-25) to learn more about long COVID, also called PASC. Researchers will track symptoms, risk factors, and health outcomes in those who had COVID-19 and those who did not. The goal is to better understand how the vir…

This study looks at whether the respiratory syncytial virus (RSV) can pass from a pregnant woman to her unborn baby. Researchers will test blood from mothers and umbilical cords to check for RSV and other viruses. They will also follow the babies for up to 4 years to see if they …

This study follows 1,520 mostly Black and Latinx adults who had COVID-19 to understand long-term health problems. Participants complete surveys and some give blood and nasal swabs up to 12 months after infection. The goal is to learn how infection severity affects recovery and im…

This study follows 500 adults who had COVID-19 to learn about long-term health issues like tiredness, shortness of breath, and lung scarring. Researchers will track recovery patterns and identify who is most at risk for lasting problems. No new treatments are tested; the goal is …

This study follows 500 children under 18 who tested positive for flu, RSV, or COVID-19. Researchers measure how long the virus stays active in their bodies and how it spreads to family members and classmates. The goal is to provide better guidance on when it's safe to return to s…

This clinical trial is testing a medical device that has not been approved by the U.S. Food and Drug Administration. The specific purpose, number of participants, and how the device works are not publicly available. The study's status is also withheld, meaning it is unclear if it…